Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
October 04 2023 - 4:30PM
Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare
company, today announced the granting of a previously disclosed
inducement award to the Company’s newly appointed Chief Financial
Officer, Scott Coiante. In accordance with Nasdaq Listing Rule
5635(c)(4), the award was approved by the Company's Compensation
Committee and made as a material inducement to Mr. Coiante’s entry
into employment with the Company.
In connection with the commencement of employment, Mr. Coiante
received restricted stock units (“RSUs”) on October 4, 2023, to
receive 20,000 shares of Agile Therapeutics, Inc. common stock.
The RSUs have a 10-year term and a four-year vesting schedule
and will vest in four equal installments over four years with the
first installment vesting on the first anniversary of Mr. Coiante’s
start date and the RSUs being fully vested on the fourth
anniversary of Mr. Coiante’s start date, subject to Mr. Coiante’s
continued service with the Company on the applicable vesting
date.
About Agile
Therapeutics, Inc.Agile
Therapeutics is a women's healthcare company dedicated to
fulfilling the unmet health needs of today’s women. Our product and
product candidates are designed to provide women with contraceptive
options that offer freedom from taking a daily pill, without
committing to a longer-acting method. Our initial product, Twirla®,
(levonorgestrel and ethinyl estradiol), a transdermal system, is a
non-daily prescription contraceptive. Twirla is based on our
proprietary transdermal patch technology, called Skinfusion®, which
is designed to allow drug delivery through the skin. For more
information, please visit the company website at
www.agiletherapeutics.com. The Company may occasionally disseminate
material, nonpublic information on the Company’s website, Twitter
account (@agilether), and LinkedIn account.
Contact:Matt RileyHead of Investor Relations
& Corporate
Communicationsmriley@agiletherapeutics.com
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Apr 2024 to May 2024
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From May 2023 to May 2024